Body Mass Index Z Score vs Weight-for-Length Z Score in Infancy and Cardiometabolic Outcomes at Age 8-10 Years.

adiposity android-to-gynoid ratio blood pressure cardiometabolic health childhood obesity childhood overweight insulin secretion insulin sensitivity lipid profile waist circumference whole body fat

Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 19 04 2021
revised: 13 07 2021
accepted: 16 07 2021
pubmed: 25 7 2021
medline: 25 11 2021
entrez: 24 7 2021
Statut: ppublish

Résumé

To confirm that World Health Organization weight-for-length z scores (zWFL) and World Health Organization body mass index z scores (zBMI) in infancy are associated with adiposity and cardiometabolic measures at 8-10 years old and to compare the predictive ability of the 2 methods. zWFL and zBMI at 6, 12, and 18 months of age were computed using data extracted from health booklets, among participants in the Québec Adipose and Lifestyle InvesTigation in Youth prospective cohort (n = 464). Outcome measures at 8-10 years included adiposity, lipid profile, blood pressure, and insulin dynamics. The relationships between zWFL, zBMI, and each outcome were estimated using multivariable linear regression models. Outcome prediction at 8-10 years was compared between the 2 methods using eta-squared and the Lin concordance correlation coefficient. zWFL and zBMI were associated with all measures of adiposity at 8-10 years. Associations with other cardiometabolic measures were less consistent. For both zWFL and zBMI across infancy, eta-squared were highly similar and the Lin coefficients were markedly high (≥0.991) for all outcomes. There was no evidence that zBMI and zWFL in infancy differed in their ability to predict adiposity and cardiometabolic measures in childhood. This lends support to the sole use of zBMI for growth monitoring and screening of overweight and obesity from birth to 18 years. ClinicalTrials.gov: NCT03356262.

Identifiants

pubmed: 34302856
pii: S0022-3476(21)00738-1
doi: 10.1016/j.jpeds.2021.07.046
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03356262']

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-214.e2

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Jean-Baptiste Roberge (JB)

CHU Sainte-Justine Research Centre, University of Montréal, Montréal, Canada; Department of Pediatrics, Faculty of Medicine, University of Montréal, Montréal, Canada.

Soren Harnois-Leblanc (S)

CHU Sainte-Justine Research Centre, University of Montréal, Montréal, Canada; School of Public Health, University of Montréal, Montréal, Canada.

Vanessa McNealis (V)

CHU Sainte-Justine Research Centre, University of Montréal, Montréal, Canada.

Andraea van Hulst (A)

Ingram School of Nursing, McGill University, Montréal, Canada.

Tracie A Barnett (TA)

CHU Sainte-Justine Research Centre, University of Montréal, Montréal, Canada; Department of Family Medicine, McGill University, Montréal, Canada.

Lisa Kakinami (L)

Department of Mathematics and Statistics, McGill University, Montréal, Canada; PERFORM Centre, Concordia University, Montréal, Canada.

Gilles Paradis (G)

Department of Epidemiology, Biostatistics and Occupational Health, Montréal, Canada.

Mélanie Henderson (M)

CHU Sainte-Justine Research Centre, University of Montréal, Montréal, Canada; Department of Pediatrics, Faculty of Medicine, University of Montréal, Montréal, Canada; School of Public Health, University of Montréal, Montréal, Canada. Electronic address: melanie.henderson.hsj@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH